Pub Date : 2025-02-01DOI: 10.1016/j.jpsychires.2024.12.043
Brad A. MacNeil, Thomas Gorman, Jason Maier
This study examined laxative and substance use in adults with an eating disorder, and the association with depression, compulsions, and obsessions. A retrospective chart review of 182 women who had a formal diagnosis of an eating disorder and were receiving specialized outpatient treatment was conducted. The chart review included questionnaires completed at intake assessment, including a demographic survey with questions asking about laxative use, substance use, and the types of substances used. Adults also reported their levels of depression, obsessions and compulsions on psychometric questionnaires. Overall, 31.3% of adults with an eating disorder endorsed engagement in laxative use. Substance use was reported by 34.6% of adults with alcohol (36%) and over the counter medications (39%) being the most endorsed substances. Engagement in laxative use and substance use did not differ across the eating disorder diagnoses of anorexia nervosa (AN), bulimia nervosa (BN) or other specified feeding or eating disorder (OSFED). Engagement in substance use was not associated with adults’ symptoms of depression, obsessions, or compulsions. Compulsions were found to be a significant predictor of engagement in laxative use. Variables associated with engagement in laxative use may help to inform the development of novel approaches for addressing these behaviors in adults with an eating disorder. More work is needed to better understand the complex interplay of these behaviors.
{"title":"Examining the associations between laxative use, substance use, depressive symptoms, and obsessions and compulsions in adults with an eating disorder","authors":"Brad A. MacNeil, Thomas Gorman, Jason Maier","doi":"10.1016/j.jpsychires.2024.12.043","DOIUrl":"10.1016/j.jpsychires.2024.12.043","url":null,"abstract":"<div><div>This study examined laxative and substance use in adults with an eating disorder, and the association with depression, compulsions, and obsessions. A retrospective chart review of 182 women who had a formal diagnosis of an eating disorder and were receiving specialized outpatient treatment was conducted. The chart review included questionnaires completed at intake assessment, including a demographic survey with questions asking about laxative use, substance use, and the types of substances used. Adults also reported their levels of depression, obsessions and compulsions on psychometric questionnaires. Overall, 31.3% of adults with an eating disorder endorsed engagement in laxative use. Substance use was reported by 34.6% of adults with alcohol (36%) and over the counter medications (39%) being the most endorsed substances. Engagement in laxative use and substance use did not differ across the eating disorder diagnoses of anorexia nervosa (AN), bulimia nervosa (BN) or other specified feeding or eating disorder (OSFED). Engagement in substance use was not associated with adults’ symptoms of depression, obsessions, or compulsions. Compulsions were found to be a significant predictor of engagement in laxative use. Variables associated with engagement in laxative use may help to inform the development of novel approaches for addressing these behaviors in adults with an eating disorder. More work is needed to better understand the complex interplay of these behaviors.</div></div>","PeriodicalId":16868,"journal":{"name":"Journal of psychiatric research","volume":"182 ","pages":"Pages 142-148"},"PeriodicalIF":3.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142983850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01DOI: 10.1016/j.jpsychires.2025.01.020
Natalie M. Walter , Cristine M. Yde Ohki , Lukasz Smigielski , Susanne Walitza , Edna Grünblatt
{"title":"Investigating the impact of omega-3 fatty acids on oxidative stress and pro-inflammatory cytokine release in iPSC-derived forebrain cortical neurons from ADHD patients","authors":"Natalie M. Walter , Cristine M. Yde Ohki , Lukasz Smigielski , Susanne Walitza , Edna Grünblatt","doi":"10.1016/j.jpsychires.2025.01.020","DOIUrl":"10.1016/j.jpsychires.2025.01.020","url":null,"abstract":"","PeriodicalId":16868,"journal":{"name":"Journal of psychiatric research","volume":"182 ","pages":"Pages 257-269"},"PeriodicalIF":3.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01DOI: 10.1016/j.jpsychires.2025.01.011
Raquel A. Osorno , Maryam Ahmadi , Kathleen P. O'Hora , Natalie L. Solomon , Mateo Lopez , Allison B. Morehouse , Jane P. Kim , Rachel Manber , Andrea N. Goldstein-Piekarski
The COVID-19 Pandemic increased the prevalence and severity of insomnia and depression symptoms. The effects of an insomnia intervention on future insomnia and depression symptoms delivered during an ongoing stressor, which may have precipitated the insomnia symptoms, is unknown. We conducted a two-arm randomized controlled pilot study to evaluate whether an insomnia intervention would improve the trajectory of insomnia and depression symptoms in the context of a global pandemic. Forty-nine individuals with clinically significant insomnia symptoms that emerged after the start of the COVID-19 Pandemic were randomized to one of two groups: one group received four sessions of Cognitive Behavioral Therapy for Insomnia (CBT-I) over five weeks via telehealth, and the other was assigned to a 28-week waitlist control group. Participants completed assessments of insomnia and depressive symptom severity at baseline (week 0) and at weeks 1–6, 12, and 28. Linear mixed-effects models were used to evaluate treatment efficacy. The MacArthur model was used to test whether improvement in insomnia symptoms mediated subsequent improvement in mood. The CBT-I group showed improved trajectories of insomnia (b = -1.03, p < 0.005, 95% CI [-1.53, −0.53]) and depressive symptoms (b = −0.47, p = 0.007, [-0.80, −0.13]) across the 28 weeks compared to the control group. The rate of improvement of insomnia symptoms during treatment mediated the subsequent improvement in depressive symptom severity following treatment (b = 2.10, p = 0.024, [0.30, 3.90]). Although the sample size was small, these results underscore the potential CBT-I in the context of an ongoing stressor to not only alleviate insomnia symptoms, but also improve depressive symptoms.
{"title":"The effects of a sleep intervention in the early COVID-19 pandemic on insomnia and depressive symptoms: Results of a randomized controlled pilot study","authors":"Raquel A. Osorno , Maryam Ahmadi , Kathleen P. O'Hora , Natalie L. Solomon , Mateo Lopez , Allison B. Morehouse , Jane P. Kim , Rachel Manber , Andrea N. Goldstein-Piekarski","doi":"10.1016/j.jpsychires.2025.01.011","DOIUrl":"10.1016/j.jpsychires.2025.01.011","url":null,"abstract":"<div><div>The COVID-19 Pandemic increased the prevalence and severity of insomnia and depression symptoms. The effects of an insomnia intervention on future insomnia and depression symptoms delivered during an ongoing stressor, which may have precipitated the insomnia symptoms, is unknown. We conducted a two-arm randomized controlled pilot study to evaluate whether an insomnia intervention would improve the trajectory of insomnia and depression symptoms in the context of a global pandemic. Forty-nine individuals with clinically significant insomnia symptoms that emerged after the start of the COVID-19 Pandemic were randomized to one of two groups: one group received four sessions of Cognitive Behavioral Therapy for Insomnia (CBT-I) over five weeks via telehealth, and the other was assigned to a 28-week waitlist control group. Participants completed assessments of insomnia and depressive symptom severity at baseline (week 0) and at weeks 1–6, 12, and 28. Linear mixed-effects models were used to evaluate treatment efficacy. The MacArthur model was used to test whether improvement in insomnia symptoms mediated subsequent improvement in mood. The CBT-I group showed improved trajectories of insomnia (b = -1.03, p < 0.005, 95% CI [-1.53, −0.53]) and depressive symptoms (b = −0.47, p = 0.007, [-0.80, −0.13]) across the 28 weeks compared to the control group. The rate of improvement of insomnia symptoms during treatment mediated the subsequent improvement in depressive symptom severity following treatment (b = 2.10, p = 0.024, [0.30, 3.90]). Although the sample size was small, these results underscore the potential CBT-I in the context of an ongoing stressor to not only alleviate insomnia symptoms, but also improve depressive symptoms.</div></div>","PeriodicalId":16868,"journal":{"name":"Journal of psychiatric research","volume":"182 ","pages":"Pages 319-328"},"PeriodicalIF":3.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143023844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Evaluate cardiometabolic risk as a potential sequel to a mass terrorist attack using October 7th, 2023 as a focus.
Methods
Narrative review surveying PubMed, PsycNet, UN and Council on Foreign Relations websites on.
1. PTSD following terrorism, rocket attacks and conflict related sexual violence.
2. The relationship between cardiometabolic illness and PTSD.
3. Humoral, genetic and epigenetic mechanisms relating cardiometabolic risk, inflammation and PTSD.
4. Treatments for PTSD and associated cardiometabolic risk factors and their effectiveness.
Findings
Cardiometabolic sequelae occur after trauma. This is most pronounced when trauma, sexual or violence related, occurs during childhood. The risk of cardiometabolic sequelae increases with PTSD diagnosis in adults. Inflammation as well as genes related to inflammatory function (e.g. FKBP5, AHRR, NR3C1) impact vulnerability to PTSD, response to treatment and cardiometabolic outcomes. Treatments for PTSD appear somewhat more effective at lowering cardiometabolic risk in civilian, rather than military populations. There is little published research on directly treating cardiometabolic sequelae of PTSD.
Conclusions
Israelis, particularly those with exposure to the terror events of October 7, 2023 should be screened for psychological and metabolic sequelae. This should occur in a primary care setting and be part of observational research to help understand relationships between trauma, metabolic outcomes and their treatment.
{"title":"Potential metabolic sequelae to the terrorist attack of October 7th, 2023","authors":"Lawrence Maayan , Eyal Kalanthroff , Ezra Cohen , Yuval Neria","doi":"10.1016/j.jpsychires.2025.01.033","DOIUrl":"10.1016/j.jpsychires.2025.01.033","url":null,"abstract":"<div><h3>Objective/hypothesis</h3><div>Evaluate cardiometabolic risk as a potential sequel to a mass terrorist attack using October 7th, 2023 as a focus.</div></div><div><h3>Methods</h3><div>Narrative review surveying PubMed, PsycNet, UN and Council on Foreign Relations websites on.</div><div>1. PTSD following terrorism, rocket attacks and conflict related sexual violence.</div><div>2. The relationship between cardiometabolic illness and PTSD.</div><div>3. Humoral, genetic and epigenetic mechanisms relating cardiometabolic risk, inflammation and PTSD.</div><div>4. Treatments for PTSD and associated cardiometabolic risk factors and their effectiveness.</div></div><div><h3>Findings</h3><div>Cardiometabolic sequelae occur after trauma. This is most pronounced when trauma, sexual or violence related, occurs during childhood. The risk of cardiometabolic sequelae increases with PTSD diagnosis in adults. Inflammation as well as genes related to inflammatory function (e.g. FKBP5, AHRR, NR3C1) impact vulnerability to PTSD, response to treatment and cardiometabolic outcomes. Treatments for PTSD appear somewhat more effective at lowering cardiometabolic risk in civilian, rather than military populations. There is little published research on directly treating cardiometabolic sequelae of PTSD.</div></div><div><h3>Conclusions</h3><div>Israelis, particularly those with exposure to the terror events of October 7, 2023 should be screened for psychological and metabolic sequelae. This should occur in a primary care setting and be part of observational research to help understand relationships between trauma, metabolic outcomes and their treatment.</div></div>","PeriodicalId":16868,"journal":{"name":"Journal of psychiatric research","volume":"182 ","pages":"Pages 452-461"},"PeriodicalIF":3.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143074597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01DOI: 10.1016/j.jpsychires.2025.01.012
Laura Blanco-Hinojo , Jesus Pujol , Gerard Martínez-Vilavella , Olga Giménez-Palop , Laia Casamitjana , Jesús Cobo , Rocío Pareja , Susanna Esteba-Castillo , Joan Deus , Assumpta Caixàs
Individuals with Prader Willi syndrome (PWS) often exhibit behavioral difficulties characterized by deficient impulse regulation and obsessive-compulsive features resembling those observed in obsessive-compulsive disorder. The genetic configuration of PWS aligns with molecular and neurophysiological findings suggesting dysfunction in the inhibitory gamma-aminobutyric acid (GABA) interneuron system may contribute to its clinical manifestation. In the cerebral cortex, this dysfunction is expressed as desynchronization of local neural activity. We used functional connectivity MRI to examine potential alterations in the local synchrony of the cerebral cortex in PWS. Whole-brain functional connectivity maps were generated using iso-distance average correlation (IDAC) measures in 22 patients with PWS and 22 control participants. Patients with PWS showed reduced local connectivity (weaker synchrony) in frontal areas, including the orbitofrontal cortex, ventral medial and lateral frontal regions, the anterior cingulate cortex, and sensory areas. The presence of obsessive-compulsive symptoms was significantly associated with the degree of functional structure alteration in part of the orbitofrontal and sensory cortices. In addition, abnormally heightened functional connectivity (stronger synchrony) was identified in the posterior cingulate cortex and the bilateral angular gyri, core components of the default mode network, with distance-dependent effects. Our findings of cortical synchrony alterations indicate a degree of overlap with the anatomy of the alterations previously observed in primary obsessive-compulsive disorder, while also suggesting the implication of GABAergic dysfunction in the pathophysiology of the disorder. Our observations may support the rational development of more specific therapeutic strategies in the treatment of behavioral disinhibition characteristic of PWS.
{"title":"Mapping alterations in the local synchrony of the cerebral cortex in Prader Willi syndrome","authors":"Laura Blanco-Hinojo , Jesus Pujol , Gerard Martínez-Vilavella , Olga Giménez-Palop , Laia Casamitjana , Jesús Cobo , Rocío Pareja , Susanna Esteba-Castillo , Joan Deus , Assumpta Caixàs","doi":"10.1016/j.jpsychires.2025.01.012","DOIUrl":"10.1016/j.jpsychires.2025.01.012","url":null,"abstract":"<div><div>Individuals with Prader Willi syndrome (PWS) often exhibit behavioral difficulties characterized by deficient impulse regulation and obsessive-compulsive features resembling those observed in obsessive-compulsive disorder. The genetic configuration of PWS aligns with molecular and neurophysiological findings suggesting dysfunction in the inhibitory gamma-aminobutyric acid (GABA) interneuron system may contribute to its clinical manifestation. In the cerebral cortex, this dysfunction is expressed as desynchronization of local neural activity. We used functional connectivity MRI to examine potential alterations in the local synchrony of the cerebral cortex in PWS. Whole-brain functional connectivity maps were generated using iso-distance average correlation (IDAC) measures in 22 patients with PWS and 22 control participants. Patients with PWS showed reduced local connectivity (weaker synchrony) in frontal areas, including the orbitofrontal cortex, ventral medial and lateral frontal regions, the anterior cingulate cortex, and sensory areas. The presence of obsessive-compulsive symptoms was significantly associated with the degree of functional structure alteration in part of the orbitofrontal and sensory cortices. In addition, abnormally heightened functional connectivity (stronger synchrony) was identified in the posterior cingulate cortex and the bilateral angular gyri, core components of the default mode network, with distance-dependent effects. Our findings of cortical synchrony alterations indicate a degree of overlap with the anatomy of the alterations previously observed in primary obsessive-compulsive disorder, while also suggesting the implication of GABAergic dysfunction in the pathophysiology of the disorder. Our observations may support the rational development of more specific therapeutic strategies in the treatment of behavioral disinhibition characteristic of PWS.</div></div>","PeriodicalId":16868,"journal":{"name":"Journal of psychiatric research","volume":"182 ","pages":"Pages 122-131"},"PeriodicalIF":3.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142983775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maladaptive Daydreaming (MD) is an excessive absorption in vivid fantasies interfering with individuals' daily functioning, which has been associated with adverse psychological outcomes and adult attachment insecurities. However, no study to date has addressed the relationships between MD, parental care, unresolved attachment, and psychological symptoms (depression/anxiety and obsessive-compulsive disorder; OCD) in a sample of young adults. In this study, 1295 young adults (401 males) completed an online survey including the Parental Bonding Instrument, Maladaptive Daydreaming Scale, Adult Unresolved Attachment Questionnaire, and the DSM-5 Level 1 Cross-Cutting Symptom Measure. The results evidenced the differential contribution of maternal and paternal care on individuals' psychological symptoms; whilst higher maternal care was negatively related to OCD symptoms, higher paternal care was negatively linked to depression/anxiety symptoms. A relationship between unresolved attachment, MD and psychopathological symptoms emerged; specifically, MD mediated the relationships between unresolved attachment and depression/anxiety and OCD symptoms. Overall, paternal and maternal care may have distinct roles in predicting individuals’ psychopathological outcomes. In the presence of unresolved attachment, MD may represent a dissociative response that allows individuals to deal with negative experiences through psychopathological symptoms. Understanding the specific pathways that lead to different psychopathological outcomes could have important implications in developing preventive clinical interventions.
{"title":"Understanding maladaptive daydreaming from the attachment framework: The intertwining roles of parental care, unresolved attachment, depression/anxiety and obsessive-compulsive symptoms","authors":"Micol Gemignani , Elisa Mancinelli , Tommaso Manari , Giulia Gagliardini , Giulia Bassi , Ilaria Chirico , Giulia Gizzi , Giulia Landi , Maria Luisa Pistorio , Virginia Pupi , Eleonora Volpato , Tania Moretta , Alessandro Musetti","doi":"10.1016/j.jpsychires.2025.01.015","DOIUrl":"10.1016/j.jpsychires.2025.01.015","url":null,"abstract":"<div><div>Maladaptive Daydreaming (MD) is an excessive absorption in vivid fantasies interfering with individuals' daily functioning, which has been associated with adverse psychological outcomes and adult attachment insecurities. However, no study to date has addressed the relationships between MD, parental care, unresolved attachment, and psychological symptoms (depression/anxiety and obsessive-compulsive disorder; OCD) in a sample of young adults. In this study, 1295 young adults (401 males) completed an online survey including the Parental Bonding Instrument, Maladaptive Daydreaming Scale, Adult Unresolved Attachment Questionnaire, and the DSM-5 Level 1 Cross-Cutting Symptom Measure. The results evidenced the differential contribution of maternal and paternal care on individuals' psychological symptoms; whilst higher maternal care was negatively related to OCD symptoms, higher paternal care was negatively linked to depression/anxiety symptoms. A relationship between unresolved attachment, MD and psychopathological symptoms emerged; specifically, MD mediated the relationships between unresolved attachment and depression/anxiety and OCD symptoms. Overall, paternal and maternal care may have distinct roles in predicting individuals’ psychopathological outcomes. In the presence of unresolved attachment, MD may represent a dissociative response that allows individuals to deal with negative experiences through psychopathological symptoms. Understanding the specific pathways that lead to different psychopathological outcomes could have important implications in developing preventive clinical interventions.</div></div>","PeriodicalId":16868,"journal":{"name":"Journal of psychiatric research","volume":"182 ","pages":"Pages 290-296"},"PeriodicalIF":3.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143007345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder often accompanied by mood disorders such as seasonal affective disorder (SAD), characterized by seasonal mood and behavioral changes. Although a genetic link between ADHD and SAD has been proposed, research on their relationship remains limited.
Methods
An online questionnaire survey was conducted to explore the relationship between ADHD traits and seasonal mood changes. The Adult ADHD Self-Report Scale (ASRS) and the Seasonal Pattern Assessment Questionnaire (SPAQ), measured by the General Seasonality Score (GSS), were used.
Results
From a sample of 3000 participants, a significant correlation was found between ASRS and GSS (r = 0.42, p < 0.001). Potential ADHD subjects had significantly higher GSS scores than non-ADHD subjects (mean 10.2 vs. 6.7, p < 0.001). The prevalence of potential SAD during winter was higher among potential ADHD participants: 8.5% in potential ADHD participants, and 2.0% in non-ADHD participants (p < 0.001). Further analyses indicated that possible ADHD participants experienced significant seasonal changes in body weight, sleep duration, and food preferences. Additional analyses using GSS as a covariate showed that changes in body weight and sleep duration were not solely due to GSS, whereas changes in food preference were significantly associated with GSS.
Conclusion
This study demonstrated that individuals with ADHD traits are more susceptible to seasonal mood variations. Additionally, ADHD traits were significantly associated with seasonal changes in body weight, sleep patterns, and food preferences. These findings underscore the importance of considering seasonal factors in clinical settings to improve the quality of life for individuals with ADHD.
{"title":"Seasonal changes in mood and behaviors in individuals with attention-deficit/hyperactivity disorder trait","authors":"Yuri Jo , Shunsuke Takagi , Masaaki Shimizu , Hidehiko Takahashi , Genichi Sugihara","doi":"10.1016/j.jpsychires.2025.01.044","DOIUrl":"10.1016/j.jpsychires.2025.01.044","url":null,"abstract":"<div><h3>Background</h3><div>Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder often accompanied by mood disorders such as seasonal affective disorder (SAD), characterized by seasonal mood and behavioral changes. Although a genetic link between ADHD and SAD has been proposed, research on their relationship remains limited.</div></div><div><h3>Methods</h3><div>An online questionnaire survey was conducted to explore the relationship between ADHD traits and seasonal mood changes. The Adult ADHD Self-Report Scale (ASRS) and the Seasonal Pattern Assessment Questionnaire (SPAQ), measured by the General Seasonality Score (GSS), were used.</div></div><div><h3>Results</h3><div>From a sample of 3000 participants, a significant correlation was found between ASRS and GSS (r = 0.42, p < 0.001). Potential ADHD subjects had significantly higher GSS scores than non-ADHD subjects (mean 10.2 vs. 6.7, p < 0.001). The prevalence of potential SAD during winter was higher among potential ADHD participants: 8.5% in potential ADHD participants, and 2.0% in non-ADHD participants (p < 0.001). Further analyses indicated that possible ADHD participants experienced significant seasonal changes in body weight, sleep duration, and food preferences. Additional analyses using GSS as a covariate showed that changes in body weight and sleep duration were not solely due to GSS, whereas changes in food preference were significantly associated with GSS.</div></div><div><h3>Conclusion</h3><div>This study demonstrated that individuals with ADHD traits are more susceptible to seasonal mood variations. Additionally, ADHD traits were significantly associated with seasonal changes in body weight, sleep patterns, and food preferences. These findings underscore the importance of considering seasonal factors in clinical settings to improve the quality of life for individuals with ADHD.</div></div>","PeriodicalId":16868,"journal":{"name":"Journal of psychiatric research","volume":"182 ","pages":"Pages 462-468"},"PeriodicalIF":3.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143074599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01DOI: 10.1016/j.jpsychires.2024.11.050
Weijing Qi (齐伟静) , Sha Huang (黄莎) , Jinping Zhao (赵金萍) , Xuefei Cui (崔雪菲) , Ziqi Wei (魏子琪) , Gaiying Cui (崔改英) , Qing Guo (郭清) , Jie Hu (胡洁)
Background
Postpartum depression is a prevalent issue that significantly impacts the mental health of women, placing a substantial burden on individuals, families, and society. With the increasing evidence of postpartum depression prevention, conducting comprehensive assessments becomes essential to facilitate future clinical practices.
Methods
The systematic review and meta-analysis examined psychological and psychosocial interventions to prevent postpartum depression in perinatal women (antenatal and postnatal up to 12 months). In January 2022 and November 2023, nine English- and four Chinese-language databases were searched. Two authors independently carried out literature screening and data extraction. To assess the quality of methodological, reporting, and evidence of the included reviews, the AMSTAR-2 scale, PRISMA statement, and GRADE approach were employed by the two authors.
Results
Twenty-eight eligible reviews were included, with medium-very low methodological quality. These reviews reported on 15 effective preventive interventions in four categories. However, due to inconsistent results across the studies, it was challenging to pinpoint the most beneficial interventions conclusively.
Limitations
Grey literature and unpublished articles were not searched, and the limitation on included reviews may result in biased results. In our narrative summary, data overlap in the original study was not considered. The low quality of the identified reviews further undermines the credibility of the evidence.
Conclusions
The study identified four promising aspects of preventive interventions, namely psychological, educational, support, and maternal-infant interventions. However, to draw more robust and reliable conclusions, future research must focus on higher-quality studies that directly compare the effectiveness of these different interventions.
{"title":"The preventive effect of psychological and psychosocial interventions on postpartum depression: An overview of systematic reviews","authors":"Weijing Qi (齐伟静) , Sha Huang (黄莎) , Jinping Zhao (赵金萍) , Xuefei Cui (崔雪菲) , Ziqi Wei (魏子琪) , Gaiying Cui (崔改英) , Qing Guo (郭清) , Jie Hu (胡洁)","doi":"10.1016/j.jpsychires.2024.11.050","DOIUrl":"10.1016/j.jpsychires.2024.11.050","url":null,"abstract":"<div><h3>Background</h3><div>Postpartum depression is a prevalent issue that significantly impacts the mental health of women, placing a substantial burden on individuals, families, and society. With the increasing evidence of postpartum depression prevention, conducting comprehensive assessments becomes essential to facilitate future clinical practices.</div></div><div><h3>Methods</h3><div>The systematic review and meta-analysis examined psychological and psychosocial interventions to prevent postpartum depression in perinatal women (antenatal and postnatal up to 12 months). In January 2022 and November 2023, nine English- and four Chinese-language databases were searched. Two authors independently carried out literature screening and data extraction. To assess the quality of methodological, reporting, and evidence of the included reviews, the AMSTAR-2 scale, PRISMA statement, and GRADE approach were employed by the two authors.</div></div><div><h3>Results</h3><div>Twenty-eight eligible reviews were included, with medium-very low methodological quality. These reviews reported on 15 effective preventive interventions in four categories. However, due to inconsistent results across the studies, it was challenging to pinpoint the most beneficial interventions conclusively.</div></div><div><h3>Limitations</h3><div>Grey literature and unpublished articles were not searched, and the limitation on included reviews may result in biased results. In our narrative summary, data overlap in the original study was not considered. The low quality of the identified reviews further undermines the credibility of the evidence.</div></div><div><h3>Conclusions</h3><div>The study identified four promising aspects of preventive interventions, namely psychological, educational, support, and maternal-infant interventions. However, to draw more robust and reliable conclusions, future research must focus on higher-quality studies that directly compare the effectiveness of these different interventions.</div></div>","PeriodicalId":16868,"journal":{"name":"Journal of psychiatric research","volume":"182 ","pages":"Pages 21-33"},"PeriodicalIF":3.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142965404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01DOI: 10.1016/j.jpsychires.2024.12.046
Laurence S. Pe , Kristine Cate S. Pe , Jiraporn Panmanee , Piyarat Govitrapong , Jenq-Lin Yang , Sujira Mukda
Bipolar disorder (BD) is a significant neuropsychiatric condition characterized by marked psychological mood disturbances. Despite extensive research on the symptomatology of BD, the mechanisms underlying its development and presentation remain unknown. Consequently, potential treatments are limited, and existing medications often cause significant side effects, leading to treatment discontinuation. Dopamine (DA) has been implicated in behavioral regulation, reward systems, and mood, highlighting the importance of the dopaminergic system in BD. Elevated levels of DA and tyrosine hydroxylase are associated with the onset of manic episodes, whereas reduced levels are linked to the depressive phase. Additionally, endogenous melatonin (MEL) levels are considerably lower in patients with BD. When administered as a treatment, exogenous MEL and MEL agonists improve behavioral characteristics and significantly modulate DA-related pathophysiological pathways in BD, with minimal adverse effects achieved through MEL receptor activation. Moreover, MEL and MEL agonists offer neuroprotection by promoting physiological homeostasis during disruption. The aim of this review is to investigate and propose MEL receptors as potential novel therapeutic targets for BD. This review seeks to analyze the role of MEL and its agonists in modulating dopamine-related pathophysiological pathways, improving behavioral outcomes, and providing neuroprotection with minimal side effects.
{"title":"Plausible therapeutic effects of melatonin and analogs in the dopamine-associated pathophysiology of bipolar disorder","authors":"Laurence S. Pe , Kristine Cate S. Pe , Jiraporn Panmanee , Piyarat Govitrapong , Jenq-Lin Yang , Sujira Mukda","doi":"10.1016/j.jpsychires.2024.12.046","DOIUrl":"10.1016/j.jpsychires.2024.12.046","url":null,"abstract":"<div><div>Bipolar disorder (BD) is a significant neuropsychiatric condition characterized by marked psychological mood disturbances. Despite extensive research on the symptomatology of BD, the mechanisms underlying its development and presentation remain unknown. Consequently, potential treatments are limited, and existing medications often cause significant side effects, leading to treatment discontinuation. Dopamine (DA) has been implicated in behavioral regulation, reward systems, and mood, highlighting the importance of the dopaminergic system in BD. Elevated levels of DA and tyrosine hydroxylase are associated with the onset of manic episodes, whereas reduced levels are linked to the depressive phase. Additionally, endogenous melatonin (MEL) levels are considerably lower in patients with BD. When administered as a treatment, exogenous MEL and MEL agonists improve behavioral characteristics and significantly modulate DA-related pathophysiological pathways in BD, with minimal adverse effects achieved through MEL receptor activation. Moreover, MEL and MEL agonists offer neuroprotection by promoting physiological homeostasis during disruption. The aim of this review is to investigate and propose MEL receptors as potential novel therapeutic targets for BD. This review seeks to analyze the role of MEL and its agonists in modulating dopamine-related pathophysiological pathways, improving behavioral outcomes, and providing neuroprotection with minimal side effects.</div></div>","PeriodicalId":16868,"journal":{"name":"Journal of psychiatric research","volume":"182 ","pages":"Pages 13-20"},"PeriodicalIF":3.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142965411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01DOI: 10.1016/j.jpsychires.2024.12.044
Clara Sayk , Nicole Koch , Janine Stierand , Felix Timpe , Hong-Viet V. Ngo , Ines Wilhelm , Klaus Junghanns
Insomnia and nightmares are present in up to 45 % of individuals with borderline personality disorder (BPD) and can contribute to challenges with emotion regulation, low sleep quality, dream anxiety, increased arousal and self-control. Despite their prevalence, nightmares are usually not addressed in classical BPD treatment. Imagery rehearsal therapy (IRT) is considered first in line treatment for nightmares, however, there are no studies to date that investigate its effects in individuals with BPD. Here we investigated a) whether IRT can be used to treat nightmares in individuals with BPD and b) whether there is an additional benefit of the intervention on symptoms associated with BPD. In a between-subjects design, 22 individuals with BPD completed eight sessions of group-IRT as an add-on to their inpatient treatment and were compared to 22 gender and age matched control participants regarding nightmares, trauma, depression and anxiety symptoms. Nightmare symptoms improved significantly during the intervention as indicated by subjective ratings. Moreover, participants in the IRT group showed a more pronounced decrease in intrusions, hyperarousal and anxiety compared to the control group. This pilot study gives a first glimpse into the feasibility and benefits of imagery rehearsal therapy in individuals with BPD. Our findings suggest that IRT may not only help treat nightmare symptoms but also reduce anxiety and trauma symptoms in BPD. Future studies should include randomized controlled trials of IRT in individuals with BPD with larger sample sizes and polysomnography in both groups.
{"title":"Imagery rehearsal therapy for the treatment of nightmares in individuals with borderline personality disorder – A pilot study","authors":"Clara Sayk , Nicole Koch , Janine Stierand , Felix Timpe , Hong-Viet V. Ngo , Ines Wilhelm , Klaus Junghanns","doi":"10.1016/j.jpsychires.2024.12.044","DOIUrl":"10.1016/j.jpsychires.2024.12.044","url":null,"abstract":"<div><div>Insomnia and nightmares are present in up to 45 % of individuals with borderline personality disorder (BPD) and can contribute to challenges with emotion regulation, low sleep quality, dream anxiety, increased arousal and self-control. Despite their prevalence, nightmares are usually not addressed in classical BPD treatment. Imagery rehearsal therapy (IRT) is considered first in line treatment for nightmares, however, there are no studies to date that investigate its effects in individuals with BPD. Here we investigated a) whether IRT can be used to treat nightmares in individuals with BPD and b) whether there is an additional benefit of the intervention on symptoms associated with BPD. In a between-subjects design, 22 individuals with BPD completed eight sessions of group-IRT as an add-on to their inpatient treatment and were compared to 22 gender and age matched control participants regarding nightmares, trauma, depression and anxiety symptoms. Nightmare symptoms improved significantly during the intervention as indicated by subjective ratings. Moreover, participants in the IRT group showed a more pronounced decrease in intrusions, hyperarousal and anxiety compared to the control group. This pilot study gives a first glimpse into the feasibility and benefits of imagery rehearsal therapy in individuals with BPD. Our findings suggest that IRT may not only help treat nightmare symptoms but also reduce anxiety and trauma symptoms in BPD. Future studies should include randomized controlled trials of IRT in individuals with BPD with larger sample sizes and polysomnography in both groups.</div></div>","PeriodicalId":16868,"journal":{"name":"Journal of psychiatric research","volume":"182 ","pages":"Pages 34-41"},"PeriodicalIF":3.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142971400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}